Streptomyces fragilis Anderson et al. (ATCC® 23908)

Strain Designations: ISP 5044 [C 1437, CBS 804.68, IFO 12862, IMRU 3732, NRRL 2424, P-D 04926, RIA 1111]  /  Type Strain: yes  /  Biosafety Level: 1

Strain Designations ISP 5044 [C 1437, CBS 804.68, IFO 12862, IMRU 3732, NRRL 2424, P-D 04926, RIA 1111]
Application
Produces azaserine
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain yes (type strain)
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor EB Shirling
Chain of Custody
ATCC <<--EB Shirling<<--L. Anderson C 1437
References

Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.

Anderson LE, et al. Strains of Streptomyces, the sources of azaserine, elaiomycin, griseoviridin, and viridogrisein. Antibiot. Chemother. 6: 100-115, 1956.

Torikata A, et al. Studies of the antibiotics from genus Actinoplanes. I. Taxonomy of the producers of three antibiotics and their isolation and identification with azaserine, 5-azacytidine and actinomycins. Annu. Rep. Sankyo Res. Lab. 30: 84-97, 1978.

Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. III. Additional species descriptions from first and second studies. Int J Syst Bacteriol 18: 279-392, 1968.

type strain

type strain